These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33208458)

  • 21. Different adaptations of IgG effector function in human and nonhuman primates and implications for therapeutic antibody treatment.
    Warncke M; Calzascia T; Coulot M; Balke N; Touil R; Kolbinger F; Heusser C
    J Immunol; 2012 May; 188(9):4405-11. PubMed ID: 22461693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function.
    Brinkhaus M; Douwes RGJ; Bentlage AEH; Temming AR; de Taeye SW; Tammes Buirs M; Gerritsen J; Mok JY; Brasser G; Ligthart PC; van Esch WJE; Verheesen P; de Haard H; Rispens T; Vidarsson G
    J Immunol; 2020 Dec; 205(12):3456-3467. PubMed ID: 33188070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes.
    Nguyen DC; Scinicariello F; Attanasio R
    Immunogenetics; 2011 Jun; 63(6):351-62. PubMed ID: 21327607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD20 rituximab IgG1, IgG3, and IgG4 but not IgG2 subclass trigger Ca
    Freitas Monteiro M; Papaserafeim M; Réal A; Puga Yung GL; Seebach JD
    J Leukoc Biol; 2020 Oct; 108(4):1409-1423. PubMed ID: 32620047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG subclasses and allotypes: from structure to effector functions.
    Vidarsson G; Dekkers G; Rispens T
    Front Immunol; 2014; 5():520. PubMed ID: 25368619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
    Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
    Front Immunol; 2020; 11():2049. PubMed ID: 32973813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.
    Zhang X; Olsen HS; Chen S; So E; Zhou H; Burch E; Mérigeon EY; Block DS; Strome SE
    J Immunol; 2016 Feb; 196(3):1165-76. PubMed ID: 26695368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.
    Wines BD; Vanderven HA; Esparon SE; Kristensen AB; Kent SJ; Hogarth PM
    J Immunol; 2016 Aug; 197(4):1507-16. PubMed ID: 27385782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.
    Sammaritano LR; Ng S; Sobel R; Lo SK; Simantov R; Furie R; Kaell A; Silverstein R; Salmon JE
    Arthritis Rheum; 1997 Nov; 40(11):1998-2006. PubMed ID: 9365089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IgG2 concentration is associated with Gm-allotypes of IgG2 but not with the R131H polymorphism of human Fc-gamma receptor type IIa.
    Sarvas H; Vesterinen P; Mäkelä O
    J Clin Immunol; 2002 Mar; 22(2):92-7. PubMed ID: 11998898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development.
    Kdimati S; Mullins CS; Linnebacher M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination.
    Lemke MM; Theisen RM; Bozich ER; McLean MR; Lee CY; Lopez E; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kratochvil S; Wines BD; Hogarth PM; Kent SJ; Chung AW; Arnold KB
    Front Immunol; 2022; 13():820148. PubMed ID: 35273603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-retroviral antibody FcγR-mediated effector functions.
    Bournazos S; Ravetch JV
    Immunol Rev; 2017 Jan; 275(1):285-295. PubMed ID: 28133801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions.
    Schlothauer T; Herter S; Koller CF; Grau-Richards S; Steinhart V; Spick C; Kubbies M; Klein C; Umaña P; Mössner E
    Protein Eng Des Sel; 2016 Oct; 29(10):457-466. PubMed ID: 27578889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine IgG1, but not IgG2, binds to human B cells and inhibits antibody secretion.
    Nash GS; MacDermott RP; Schloemann S; Bertovich MJ; O'Neal J; Porter L; Kulczycki A
    Immunology; 1990 Mar; 69(3):361-6. PubMed ID: 2312161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes.
    Attanasio R; Jayashankar L; Engleman CN; Scinicariello F
    Immunogenetics; 2002 Nov; 54(8):556-61. PubMed ID: 12439618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
    Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
    J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.